Insider Transactions in Q2 2022 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2022
|
Kaye I Foster Cheek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+15.34%
|
-
|
|
May 20
2022
|
John Maraganore Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+5.01%
|
-
|
|
May 20
2022
|
Maykin Ho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+19.49%
|
-
|
|
May 20
2022
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+1.33%
|
-
|
|
May 20
2022
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+19.49%
|
-
|
|
May 20
2022
|
David Scadden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+18.21%
|
-
|
|
May 20
2022
|
Paul J Clancy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+19.49%
|
-
|